World News

Shanghai-based Raas disclosed the proposed acquisition in a financial filing, stating that it plans to acquire a 100% stake in Boehringer Ingelheim Biopharmaceuticals in China.

The European Union has mobilised €500 million (US$586 million) in emergency aid, vaccines, treatment and health security support for the Great Lakes and Uganda region.

The agreement brings together BoomRay’s expertise in radioligand therapy development and Novartis’ global capabilities in radiopharmaceutical research and commercialisation.

In its new publication, WHO Guidelines on Expanding Contraceptive Options, WHO provides countries with evidence-based recommendations to broaden access to contraceptive methods and offer more flexibility in how people use them.

The collaboration will assess selected targets for several therapeutic approaches, including antibody-drug conjugates (ADCs), multispecific antibodies and T cell engagers (TcEs).

The facility can produce starting materials, drug substances and drug products using customised processes as well as technology transferred from established manufacturing platforms.

TAVI is widely used to treat severe aortic stenosis, a condition in which narrowing of the aortic valve restricts blood flow from the heart.

Following completion of the acquisition, ITM shareholders are expected to hold 23.7% of Telix, while existing Telix shareholders will retain 76.3%.

The agreement covers licensing, development, manufacturing and commercialisation of the candidate, which is currently in the early stages of development.

Researchers will need about 55,000 participants to support currently active studies.